en
E-mail us
(925) 558-5040
bd_global@crystalpharmatech.com
 cn
cn
Whitepaper Technical Insight Blog Case Study Presentation
Showing 8 out of 8 results
Predicting Solid-Form Change Under Real-World Humidity and Temperature Conditions
Blog
Predicting Solid-Form Change Under Real-World Humidity and Temperature Conditions
This practical CMC guide shows how humidity and temperature together affect solid forms, influence stability and manufacturability, and support better study design, control strategies, and packaging decisions
26 Mar 2026
Mini-Tablet, Major Impact: From Lab to Commercial Scale
Blog
Mini-Tablet, Major Impact: From Lab to Commercial Scale
Crystal Pharmatech’s integrated mini-tablet platform accelerates development from lab to commercial scale. We provide precision engineering, 505(b)(2) expertise, and high-precision filling for APIs.
25 Mar 2026
Short Half-Life vs. Once-a-Day Dosing: Breaking the Barrier
Blog
Short Half-Life vs. Once-a-Day Dosing: Breaking the Barrier
A short half-life doesn't rule out QD dosing. By leveraging Modified Release (MR) to flatten PK curves and addressing pillars like absorption windows and solubility, developers can bridge the gap from IR to once-daily regimens, ensuring patient compliance and therapeutic differentiation.
18 Mar 2026
The Race to FIH: How Fast Can You Reach the Clinic?
Blog
The Race to FIH: How Fast Can You Reach the Clinic?
We want to move fast to first-in-human. How quickly can formulation and clinical supply be ready for IND?In the high-stakes world of drug development, speed is the ultimate currency. But as the saying...
12 Mar 2026
Peptide Crystallization Process Development: A Practical CMC Guide for Peptide APIs
Blog
Peptide Crystallization Process Development: A Practical CMC Guide for Peptide APIs
Peptide crystallization process development can transform peptide API stability, filtration, and downstream manufacturability. Learn high-throughput screening, salt and polymorph screening, seeding, a...
11 Mar 2026
Conquering the “Uncrystallizable”: Advanced Strategies for PROTAC Solid-Form Development
Blog
Conquering the “Uncrystallizable”: Advanced Strategies for PROTAC Solid-Form Development
In the world of drug development, PROTACs (Proteolysis Targeting Chimeras) are notoriously difficult to crystallize. Their high molecular weight, inherent flexibility, and complex surface area often l...
10 Mar 2026
The “Double-Limited” Challenge: Is ASD Always the Answer?
Blog
The “Double-Limited” Challenge: Is ASD Always the Answer?
When a compound is both solubility and permeability limited, the reflex is often to reach for ASD. But is that always the right move? We walk through the systematic framework our team uses to find the true bottleneck.
05 Mar 2026
First-Time-Right Formulation, Built with Full Lifecycle Intent
Blog
First-Time-Right Formulation, Built with Full Lifecycle Intent
How early formulation decisions shape the entire drug development lifecycle and why getting it right the first time matters more than ever.
24 Feb 2026
Small Molecule
First-Time-Right 3-STEP Approach Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Analytical Research and Quality Control Formulation Development Clinical and Commercial GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Crystal NAX
DNA Synthesis RNA Synthesis LNP Formulation Services Analytical & Characterization Services Early-Phase Manufacturing Catalogue Products
Platforms
Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides Mini-tablet
Quick Links
Highlights News Events Knowledge Hub Webinar Series
Contact Us
bd_global@crystalpharmatech.com (925) 558-5040
U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Floor 1, Bldg. 3, 68 Chunpu Road, Suzhou Industrial Park, Suzhou, China 215123
Subscribe to be the first to get the updates!

Subscribe to be the first to get the updates!

Privacy Policy
Sitemap
Small Molecule
First-Time-Right 3-STEP Approach Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Analytical Research and Quality Control Formulation Development Clinical and Commercial GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Platforms
Quick Links
About Us Events
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
bd_global@crystalpharmatech.com (925) 558-5040
Privacy Policy
Sitemap